Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 73,551 | 256,965 | 187,661 | 39,904 | 33,589 |
| Marketable Securities | 136,793 | 7,250 | N/A | N/A | N/A |
| Receivables | 2,416 | 3,530 | 4,713 | 3,633 | 3,224 |
| Other current assets | 35,036 | 3,061 | 1,534 | 1,647 | 1,025 |
| TOTAL | $247,796 | $270,806 | $193,908 | $45,184 | $37,838 |
| Non-Current Assets | |||||
| PPE Net | 38,501 | 15,049 | 3,397 | 4,265 | 2,070 |
| Investments And Advances | 782 | 647 | 0 | 0 | 0 |
| Intangibles | 5,891 | 5,042 | 4,913 | 4,764 | 3,980 |
| Other Non-Current Assets | 2,063 | 25 | 2,775 | 155 | 2,088 |
| TOTAL | $47,237 | $20,763 | $11,085 | $9,184 | $8,138 |
| Total Assets | $295,033 | $291,569 | $204,993 | $54,368 | $45,976 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 98 | 92 | 89 | 85 | 81 |
| Accounts payable and accrued liabilities | 12,408 | 8,080 | 7,532 | 9,396 | 1,311 |
| Accrued Expenses | 17,366 | 14,601 | 2,741 | 2,244 | 2,015 |
| Other current liabilities | 1,185 | 9,894 | 65,220 | 5,572 | 39,146 |
| TOTAL | $36,867 | $35,966 | $78,886 | $20,601 | $45,857 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,738 | 1,576 | 1,668 | 1,757 | 1,842 |
| Deferred Revenues | 3,318 | 3,299 | 3,304 | 3,304 | 3,304 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 993 | 1,094 |
| TOTAL | $10,513 | $8,411 | $2,428 | $2,750 | $2,936 |
| Total Liabilities | $47,380 | $44,377 | $81,314 | $23,351 | $48,793 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,312 | 37,775 | 31,831 | 22,628 | 18,764 |
| Common Shares | 4 | 4 | 3 | 2 | 11 |
| Retained earnings | -679,025 | -543,236 | -431,251 | -309,964 | -307,646 |
| Other shareholders' equity | -95 | 0 | 0 | 0 | 0 |
| TOTAL | $247,653 | $247,192 | $123,679 | $31,017 | $-2,817 |
| Total Liabilities And Equity | $295,033 | $291,569 | $204,993 | $54,368 | $45,976 |